CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 187 filers reported holding CARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,104,610 | +16.5% | 195,960 | +1.5% | 1.07% | +61.6% |
| Q3 2022 | $1,806,000 | -44.0% | 193,000 | -45.4% | 0.66% | -48.7% |
| Q2 2022 | $3,225,000 | +60.8% | 353,200 | +114.1% | 1.29% | +92.3% |
| Q1 2022 | $2,005,000 | -6.4% | 165,000 | +10.0% | 0.67% | +35.0% |
| Q2 2021 | $2,141,000 | – | 150,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |